Global lab scale ACM Global Laboratories is a large, globally servicing central lab with operations in over 65 countries and annual test volume exceeding 20 million. This indicates readiness to handle high-volume clinical trials and multinational studies, suggesting sales opportunities in expansive trial networks and scalable testing partnerships.

Toxicology leadership ACM expanded via DrugScan and DSI Medical Services, strengthening its toxicology and drug testing credentials. This presents cross-sell opportunities to pharmaceutical companies and CROs needing integrated toxicology, abuse-deterrent testing, and drug program management services.

Clinical trials focus Strong emphasis on supporting clinical trials, infectious disease testing, and vaccine studies, including COVID-19 related initiatives. Sales opportunities exist in trial sponsors and CROs seeking specialized central lab capabilities, assay validation, and rapid turnaround for trial milestones.

Certifications and reliability CAP and SAMHSA certifications position ACM as a compliant, quality-focused partner. Highlight reliability, data integrity, and regulatory alignment to win bids requiring stringent quality standards and audit-ready labs.

Technology backbone Tech stack includes STARLIMS, SQL, and other enterprise tools, enabling robust data management and reporting. This supports selling value around integrated data platforms, seamless EDC/LIMS interoperability, and advanced analytics for trial dashboards.